Full-Time
Electronics Engineer R&D
CooperSurgical
1,001-5,000 employees
Provides reproductive health products and services
No salary listed
Cornwall, UK
In Person
On-site in Falmouth; must be eligible to work in the UK.
 Electrical Engineering (2) |
|---|
| , |
- BSc / BEng in Electronics, Electrical Engineering, Robotics, Mechatronics or combination of related fields.
- ≥ 2 years of experience from a similar role,- preferable medical device production
- Expertise in analog and digital circuit design and layout using tools like Altium Schematic Capture.
- Strong background in hardware/software integration and hardware debugging using appropriate tools and lab instruments.
- Hands-on craft skills and experience with building circuits, soldering, fixing, servicing and/or fabricating concepts, fixtures, and prototypes..
- Strong protocol and report writing skills.
- Understanding of Design for Manufacturing and Assembly (DFMA)
- Fluent English (spoken and written) is mandatory
- Develop and design electrical systems.
- Drive successful verification and validation testing.
- Ensure 60601 EMC and Safety requirements.
- Demonstrate functional feasibility of technical solutions.
- Communicate key technical content to stakeholders.
- Generate and maintain required Medical Device documentation.
- Contribute to the creation and maintenance of risk management files.
What CooperSurgical does: CooperSurgical develops and provides products, technologies, and services that support women’s, babies’, and families’ health around the world. How its products work: The company offers a range of reproductive health solutions, including contraception, fertility support, and preventive and therapeutic gynecological care. These products assist clinicians and patients through devices, tests, and therapies designed to aid choice and care in reproductive health. How it differs from competitors: CooperSurgical focuses on a broad set of reproductive health needs—covering contraception, fertility, and gynecologic care—trusted by clinicians worldwide for a wide range of tools and services, which can enable more integrated care compared to providers focused on a narrower segment. Goal: To empower individuals and healthcare professionals to make informed health and life choices and improve care for women, babies, and families globally.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Trumbull, Connecticut
Founded
1990
Simplify's Take
What believers are saying
- Direct sales model strengthens customer relationships and improves data access in mature European markets.
- Granata Bio investment positions CooperSurgical to capture emerging reproductive health biopharma innovations.
- obp Surgical acquisition expands specialty surgery portfolio beyond women's health into adjacent surgical markets.
What critics are saying
- Massachusetts lab quality control scandal triggers regulatory investigations into IVF product testing procedures.
- European direct sales rollout faces reimbursement denials in France and Germany, limiting adoption.
- obp Surgical integration stalls due to single-use retractor technology misalignment with existing portfolio.
What makes CooperSurgical unique
- Direct-to-provider sales model in France, Italy, Germany, Spain eliminates distributor margins.
- Integrated portfolio spans fertility, labor/delivery, and specialty surgery via obp and Zymōt acquisitions.
- Proprietary sperm separation technology and single-hand IUD inserter reduce procedural complexity.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at CooperSurgical who can refer or advise you
Benefits
Health Insurance
401(k) Retirement Plan
Parental Leave
Fertility Treatment Support
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
Company News
CooperSurgical to launch direct sales model for Labor and Delivery portfolio in key european markets. TRUMBULL, CT, December 11, 2025, CooperSurgical(R), a leader in women's healthcare and fertility solutions, today announced a strategic shift to a direct sales model for its premier Labor and Delivery products in France, Italy, Germany, and Spain. This transition will forge a closer relationship with healthcare providers, reinforcing the company's commitment to advancing the standard of care for women and babies. Beginning in the company's fiscal first quarter, healthcare providers and healthcare facilities in these markets will gain the ability to procure products directly from CooperSurgical. The portfolio includes the vacuum-assisted delivery products, Fetal Pillow(TM) cephalic elevation device, the INSORB(R) subcuticular skin stapler, and the Lone Star(R) retractor system. This change from a distributor-led model is designed to streamline the customer's ordering process, facilitate easier access to these critical technologies, and provide direct support from CooperSurgical's dedicated customer care center. By creating a direct channel, CooperSurgical aims to better support the clinical community, ensuring that physicians have the resources and guidance needed to implement these innovative solutions effectively. This initiative is central to the company's mission of delivering technologies that support healthier families. About CooperSurgical CooperSurgical is a leading company dedicated to advancing the health of women, babies, and families. The company's portfolio offers effective solutions that support clinical efficiency from conception to delivery. With a history of innovation in the fertility and women's health field, CooperSurgical has pioneered new technologies and continues to drive progress in the industry. Existing Customers - Order directly from CooperSurgical Previously purchased through a distributor? CooperSurgical, Inc. has simplified the process. Its dedicated sales team can assist with product availability, pricing, ordering, and delivery information specific to your country
North America's largest provider of fertility services collaborates, celebrates achievements in fertility care including unparalleled patient services. HOUSTON, March 10, 2025 /PRNewswire/ -- Inception Fertility™ (Inception), North America's largest provider of comprehensive fertility services, held its Annual Inception Physician Summit in Nashville, Tennessee, February 22-25, 2024. The Summit brings together team members, including reproductive specialists and clinical managers, from across Inception's vast network of global fertility clinics, The Prelude Network®, to share best practices and resources that make each clinic a leading fertility provider in their respective markets
Granata Bio Corporation, a biopharma company in Boston, MA, raised $15 million in Series A+ funding. Investors included Gedeon Richter, CooperSurgical, and Amboy Street Ventures. The funds will support the company's pipeline and exploration of new assets in reproductive health. Granata Bio has raised over $30 million to date.
Four plaintiffs have filed separate lawsuits against CooperSurgical Inc., accusing the company of selling defective embryo culture which caused embryos to die.
CooperSurgical has introduced a new single-hand inserter for the Paragard copper intrauterine device (IUD).